No results for ‘’
Entero Healthcare Solutions Ltd
NSE: ENTERO BSE: 544122
₹1089.40
(1.46%)
Sat, 20 Jun 2026, 10:48 pm
Market Cap (in Cr)4751.53
PE Ratio41.27
Dividend0
Distribution Services
Medical Distributors
24.5KCompany History
2018
- The Company was incorporated as Entero Healthcare Solutions Private Limited.
- The Company received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.
- The Company acquired Novacare Healthcare Solutions Private Limited, its first acquisition.
2019
- The Company crossed a monthly turnover of 1000 million.
2020
- The Company achieved positive EBITDA in its second year of being operational.
- The Company entered into a promotion, marketing and distribution partnership with Roche Products (India) Private Limited.
2021
- The Company was recognized as one of The Economic Times - Best Healthcare Brands 2021.
2022
- The Company acquired SS Pharma Traders Private Limited, its 32nd acquisition.
2023
- The Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of Shareholders.
- The name of the Company was changed to Entero Healthcare Solutions Limited.
- A fresh certificate of incorporation was issued by the Registrar of Companies.
2024
- The Company acquired Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited.
- The Company Board of Directors approved the acquisition of Devi Pharma Wellness Private Limited.
- The Company acquired 80% paid-up equity share capital of Avenir Lifecare Pharma Pvt. Ltd.